EUVIMEDEUVIMED entdecken
Crossref

In Vitro Cytogenotoxicity of Iohexol in Bronchial Epithelial Cells and In Silico DNA and BCL‐XL Affinity Studies

Ibrahim Halil Kenger, Batuhan Bilgin iD

Journal of Applied Toxicology · 2025

DOI: 10.1002/jat.4800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2025. Verfasst von Ibrahim Halil Kenger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Gaziantep Islam Science and Technology University, Gaziantep, Turkey. Hauptthemen laut MEDLINE: Iohexol, Epithelial Cells, Bronchi, DNA Damage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iohexol is a nonionic contrast agent used in x‐ray imaging but can sometimes cause anaphylactic reactions. The mechanism of anaphylaxis‐induced fatal respiratory symptoms remains unclear. The aim of this study was to investigate the effects of iohexol on cytotoxicity and DNA damage in bronchial epithelial cells (BEAS‐2B). BEAS‐2B cells were treated with Iohexol (1.5, 15, 75, and 150 mg I/mL) and cell viability was examined by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium bromide (MTT) assay. The IC 50 value of iohexol was determined and the DNA damage effect of iohexol (12.4, 24.9, 49.9, and 99.9 mM) on BEAS‐2B cells was investigated by Comet assay. Molecular docking analysis was also performed to determine the binding affinity to DNA and the antiapoptotic protein BCL‐XL. Iohexol 15 mg I/mL, iohexol 75 mg I/mL, and iohexol 150 mg I/mL groups significantly decreased cell viability compared to the control group ( p < 0.0001). Iohexol (12.4, 24.9, 49.9, and 99.9 mM) did not significantly alter genotoxicity in BEAS‐2B cells compared to the control group ( p > 0.05). In silico study showed that iohexol binds with high affinity to BCL‐XL but low affinity to DNA. Our results show that iohexol causes cytotoxicity in BEAS‐2B cells and binds strongly to BCL‐XL. Our results suggest that the safety of iohexol needs further detailed studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IohexolEpithelial CellsBronchiDNA Damagebcl-X ProteinDNAContrast MediaHumansCell SurvivalMolecular Docking SimulationCell LineComet AssayDose-Response Relationship, DrugComputer Simulation

Stichwörter der Autor:innen

BEAS‐2BIohexolcytotoxicitygenotoxicitymolecular docking

Substanzen

Iohexolbcl-X ProteinDNAContrast MediaBCL2L1 protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, Gaziantep Islam Science and Technology University, Gaziantep, Turkey.
  • Department of Biophysics, Faculty of Medicine, Gaziantep Islam Science and Technology University, Gaziantep, Turkey.

ORCID-Profile: Batuhan Bilgin

Zitieren

APA

Kenger, I. H., & Bilgin, B. (2025). In Vitro Cytogenotoxicity of Iohexol in Bronchial Epithelial Cells and In Silico DNA and BCL‐XL Affinity Studies. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4800

Vancouver

Kenger IH, Bilgin B. In Vitro Cytogenotoxicity of Iohexol in Bronchial Epithelial Cells and In Silico DNA and BCL‐XL Affinity Studies. Journal of Applied Toxicology. 2025. doi:10.1002/jat.4800

BibTeX
@article{Kenger2025,
  author = {Kenger, Ibrahim Halil and Bilgin, Batuhan},
  title = {In Vitro Cytogenotoxicity of Iohexol in Bronchial Epithelial Cells and In Silico DNA and BCL‐XL Affinity Studies},
  journal = {Journal of Applied Toxicology},
  year = {2025},
  doi = {10.1002/jat.4800}
}
Kostenlos starten →